New

AI v2.0 Beta Launched. Experience the future of pharmaceutical care.

Try Now
Drug info language
Switches all medical info on this page (labels, indications, leaflet) without changing the rest of the interface.
Highly Regulated (List I)

MENOPUR

75UI FSH/75UI LH/Powder + Solvent/MENOTROPINE OU HORMONE GONADOTROPHINE POST MENOPAUSIQUE HUMAINE HMG EXPRIME EN HORMONE FOLLICULOSTIMULANTE FSH/HORMONE LUTEINISANTE LH
FERRING
ManufacturerVerified lab

FERRING

Public retail price
N/ADZD
Reference price (TR): 2244.00 DZD

Identification

Active ingredient (INN)
MENOTROPINE OU HORMONE GONADOTROPHINE POST MENOPAUSIQUE HUMAINE HMG EXPRIME EN HORMONE FOLLICULOSTIMULANTE FSH/HORMONE LUTEINISANTE LH
Internal code
09 J 046
Country of Origin
France
Pharmaceutical form
Powder + Solvent
Prescription List
Highly Regulated (List I)
Packaging
b/05fl. de pdre. + 05 ampoule. de solvt. de 1ml
MENOPUR
Clinical View
Highly Regulated (List I)

DAWA Clinical Workbench v2.0

Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.

Description

Gonadorelin is another name for gonadotropin-releasing hormone (GnRH).

It is a synthetic decapeptide prepared using solid phase peptide synthesis.

GnRH is responsible for the release of follicle stimulating hormone and leutinizing hormone from the anterior pituitary.

Indications

For evaluating the functional capacity and response of the gonadotropes of the anterior pituitary also for evaluating residual gonadotropic function of the pituitary following removal of a pituitary tumor by surgery and/or irradiation.

Pharmacodynamics

Gonadorelin is responsible for the release of follicle stimulating hormone and leutinizing hormone from the anterior pitutitary.

In the pituitary GnRH stimulates synthesis and release of FSH and LH, a process that is controlled by the frequency and amplitude of GnRH pulses, as well as the feedback of androgens and estrogens.

The pulsatility of

GnRH secretion has been seen in all vertebrates, and it is necessary to ensure a correct reproductive function.

Thus a single hormone, GnRH, controls a complex process of follicular growth, ovulation, and corpus luteum maintenance in the female, and spermatogenesis in the male.

Its short half life requires infusion pumps for its clinical use.

Mechanism of Action

Gonadotropin-releasing hormone receptor Agonist

Putative gonadotropin-releasing hormone II receptor Agonist.

Half-life

Very short, initial, 2-10 minutes; terminal, 10-40 minutes.

Adverse Effects

Improve decision support & research outcomes With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.

View sample adverse effects data in our new Data Library! See the data Improve decision support & research outcomes with our structured adverse effects data.

Alternatives